安必平(688393.SH):南京乾靖拟减持不超过1.61%股份

Core Viewpoint - Anbiping (688393.SH) announced that its shareholder, Nanjing Qianjing Venture Capital Partnership (Limited Partnership), plans to reduce its holdings in the company by up to 1.61% of the total share capital through centralized bidding and block trading methods [1] Group 1 - Nanjing Qianjing intends to reduce its shareholding by a maximum of 1.5 million shares, which represents 1.61% of the company's total share capital [1] - The reduction will occur in two phases: up to 935,700 shares (1.00% of total share capital) through centralized bidding and up to 566,700 shares (0.61% of total share capital) through block trading [1] - The share reduction will take place within three months after the announcement, starting 15 trading days from the date of the announcement [1]

LBPMedicine-安必平(688393.SH):南京乾靖拟减持不超过1.61%股份 - Reportify